Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves IND for cystic fibrosis drug

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

First European clinical trials of pranlukast reported

Aug. 11, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Allegra now available in Canada

Aug. 6, 1997

Anti-IL-4 MAb effective in murine model of asthma

Aug. 5, 1997

Leukotriene synthesis inhibitors in development at Bayer

Aug. 5, 1997

Nonpeptide NK3 antagonists from SmithKline Beecham

Aug. 5, 1997

HMR discovers elastase inhibitors and prodrugs thereof

July 31, 1997

Device for snoring cleared by FDA

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...